2006
DOI: 10.1007/bf03256215
|View full text |Cite
|
Sign up to set email alerts
|

Detection of Low Levels of the Mitochondrial tRNALeu(UUR) 3243A>G Mutation in Blood Derived from Patients with Diabetes

Abstract: The PARFAH method not only provides a sensitive, high-throughput, and cost-effective strategy for the detection of low levels of mtDNA mutations in peripheral tissues, but also facilitates the estimation of the percentage of mutant DNA in the sample. The fact that samples can be readily obtained from peripheral tissues in many cases will avoid the need for invasive muscle biopsies. Our ability to detect low levels of mtDNA mutations in blood samples of carriers will allow us to reassess the prevalence of the M… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0
2

Year Published

2008
2008
2012
2012

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 10 publications
(15 citation statements)
references
References 28 publications
0
11
0
2
Order By: Relevance
“…A female carrying a pathogenic mtDNA mutation is at risk of passing the mutation to her offspring, even if she is asymptomatic with low-level heteroplasmy in somatic cells. In addition, there is growing evidence that somatic mtDNA alterations are associated with aging and a variety of common diseases, including diabetes and cancers (5)(6)(7)(8)(9)(10).…”
Section: © 2012 American Association For Clinical Chemistrymentioning
confidence: 99%
“…A female carrying a pathogenic mtDNA mutation is at risk of passing the mutation to her offspring, even if she is asymptomatic with low-level heteroplasmy in somatic cells. In addition, there is growing evidence that somatic mtDNA alterations are associated with aging and a variety of common diseases, including diabetes and cancers (5)(6)(7)(8)(9)(10).…”
Section: © 2012 American Association For Clinical Chemistrymentioning
confidence: 99%
“…In fact, it now appears that about 1% of all Type II diabetes, a classic heterogeneous complex polygenic disease like autism, is due to this one mtDNA mutation, making it by far the most common known cause of diabetes mellitus. Many other mtDNA mutations that affect mitochondrial protein synthesis can also be expressed as type II diabetes and it is known that a patient is four times more likely to inherit type II diabetes from his mother than his father, consistent with mtDNA's pattern of inheritance [18] . Finally, mild mtDNA mutations have been associated with late-onset diseases [16] .…”
Section: Introductionmentioning
confidence: 93%
“…At a high percentage mutant (75-95%), this mutation can cause mitochondrial myopathy, stroke-like episodes and/or cardiac conduction defects and cardiomyopathy. However, at low levels of mutant (10-30%), this same mutation causes what appears to be a very different disease, Type II diabetes [18] . In fact, it now appears that about 1% of all Type II diabetes, a classic heterogeneous complex polygenic disease like autism, is due to this one mtDNA mutation, making it by far the most common known cause of diabetes mellitus.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…These include high pressure liquid chromatography (dHPLC) of heteroduplexes (van den Bosch et al, 2000), restriction analysis resolved by dHPLC (Procaccio et al, 2006), luminex genotyping (Fuku et al, 2007), Surveyor nuclease-mediated heteroduplex digestion (Bannwarth et al, 2005), etc. Unfortunately, these methods can be limited by low throughput, high cost, inability to quantify heteroplasmy, or complexity in interpreting the results.…”
Section: Introductionmentioning
confidence: 99%